Liver Cancer Treatment in Raipur

Liver cancer is among the most clinically complex malignancies managed in India today, with incidence rising alongside increasing rates of chronic hepatitis B and C infection, non-alcoholic fatty liver disease, and alcohol-related cirrhosis. Hepatocellular carcinoma (HCC) develops within tissue that is often already cirrhotic, narrowing the treatment window and making early diagnosis decisive. Ramkrishna CARE Hospitals, Raipur, delivers the full spectrum of liver cancer care within a single integrated centre. This article explains liver cancer symptoms, types, causes and treatment modalities.

What Is Liver Cancer?

Liver cancer describes malignant tumours arising in hepatic tissue. The liver performs over 500 important functions, including detoxification, protein synthesis and bile production. Malignant proliferation in liver cells disrupts hepatic architecture. Tumour can spread via the portal venous system to lymph nodes and distant organs. Treatment pathways and prognoses differ substantially between tumour types.

Types of Liver Cancer

Several distinct tumour types develop from different cell populations within the liver. Common types are:

• Hepatocellular carcinoma (HCC): HCC is the most prevalent primary liver cancer, comprising 75 to 85% of all cases, arising from hepatocytes in the setting of chronic liver injury or cirrhosis.
• Intrahepatic cholangiocarcinoma (ICC): Originates from bile duct epithelium within the liver, accounts for 10 to 15% of primary hepatic malignancies, and is associated with primary sclerosing cholangitis.
• Hepatoblastoma: It is a rare embryonal tumour occurring almost exclusively in children under five years of age and responds well to cisplatin-based chemotherapy combined with surgery.
• Vascular tumours: Angiosarcoma and epithelioid haemangioendothelioma are rare vascular tumours and carry a poor prognosis.

Symptoms of Liver Cancer

In the early stage liver cancer is frequently asymptomatic. However, symptoms emerge once the tumour has grown substantially or impaired hepatic function.

Persistent right upper quadrant or epigastric abdominal pain, typically described as a dull, constant ache, is the most common presenting symptom. Other symptoms are

• Jaundice
• Abdominal distension from ascites
• Early satiety
• Fatigue
• Pale stools and dark urine 
• Unexplained weight loss
• Rarely, liver cancer red spots on skin (petechiae) can occur.

Liver Cancer Causes

Liver cancer develops through a multifactorial process in which chronic hepatic injury drives genetic mutations within proliferating hepatocytes.

• Chronic hepatitis B virus (HBV) infection is the leading global cause of HCC and can trigger malignant transformation even without cirrhosis through direct viral DNA integration.
• Chronic hepatitis C virus (HCV) drives sustained hepatic inflammation progressing to cirrhosis and HCC in some infected individuals over the years.
• Alcohol-related liver disease, non-alcoholic steatohepatitis (NASH), aflatoxin B1 exposure, type 2 diabetes and obesity each contribute independently to HCC risk.

Diagnostic Tests for Liver Cancer

Diagnosis combines serological markers, cross-sectional imaging, and, where required, tissue biopsy to characterise tumour biology and establish staging:

• Blood tests: Serum alpha-fetoprotein (AFP) levels above 400 nanograms per millilitre support the diagnosis of HCC when accompanied by imaging findings.
• Liver function tests: Assess hepatic reserve like enzymes, proteins, and bilirubin
• Viral hepatitis tests: Check for Hepatitis B or C
• Contrast-enhanced CT (CECT): It is the primary imaging modality; HCC appears as arterial-phase enhancement with portal venous washout (a pathognomonic vascular signature).
•  MRI: Offers superior characterisation for lesions under two centimetres 
• Biopsy: Liver biopsy is reserved for non-diagnostic cases.

Staging by the BCLC system classifies patients from stage 0 (very early) to stage D (terminal) based on tumour burden, portal hypertension, and Child-Pugh hepatic reserve.

Risk of Liver Cancer

Certain clinical and demographic factors substantially increase the lifetime probability of developing hepatic malignancy. They are:

• Chronic HBV or HCV infection carries a lifetime HCC risk 
• Cirrhosis from any cause
• Male gender (Men face a higher baseline risk) 
• Age above 40 years with HBV
• Family history of liver cancer
• Heavy alcohol use 

Complications of Liver Cancer

Untreated or advanced liver cancer carries a spectrum of life-threatening complications:

• Variceal haemorrhage
• Hepatic encephalopathy
• Spontaneous tumour rupture 
• Biliary obstruction
• Distant metastasis to the lungs and bone
• Hepatorenal syndrome in decompensated cirrhosis.

Liver Cancer Treatment 

Treatment selection is guided by tumour stage, hepatic reserve, performance status, and multidisciplinary tumour team consensus:

• Surgical resection: Anatomical hepatectomy of the tumour-bearing segment is preferred for solitary tumours that are localised and have a future liver remnant exceeding 25%.
• Liver transplantation: Replacement of the diseased liver with a healthy donor liver that achieves a high survival rate by treating both the tumour and underlying cirrhosis simultaneously.
• Radiofrequency ablation (RFA) or microwave ablation (MWA): Induces coagulative necrosis in tumours under three centimetres via percutaneous electrodes, targeting a one-centimetre safety margin.
• Embolisation Procedures: Treatments like transarterial chemoembolisation (TACE) or radioembolisation deliver a therapeutic agent and an embolic agent via the hepatic artery for intermediate-stage tumour not amenable to resection or ablation.
• Systemic therapy: In advanced HCC doctors may suggest targeted therapy and immunotherapy based on the tumour type.

Prevention of Liver Cancer

Primary prevention through vaccination, antiviral therapy and metabolic risk modification substantially reduces population-level liver cancer burden:

• Hepatitis B vaccination is the most effective single preventive intervention and is included in India's Universal Immunisation Programme.
• Treating HBV and HCV immediately reduces HCC risk. DAA regimens cure HCV in over 95% of patients within eight to twelve weeks.
• Limiting alcohol, maintaining a healthy body weight, controlling blood glucose and six-monthly ultrasound surveillance in cirrhotic patients or chronic HBV carriers constitute the EASL-endorsed preventive standard.

Why Choose Ramkrishna CARE Hospitals for Liver Cancer Treatment in Raipur?

Ramkrishna CARE Hospitals, Raipur, operates a dedicated hepato-oncology unit that brings together hepatologists, hepatobiliary surgeons, interventional radiologists, medical oncologists and radiation oncologists under a single multidisciplinary tumour board. Patients benefit from integrated care across diagnosis, staging, treatment and surveillance within a single provider. The hospital performs anatomical liver resections and ablative procedures using intraoperative ultrasound guidance with an intensive care unit calibrated to manage the haemodynamic complexity of hepatic surgery.

The interventional suite supports TACE and SIRT; the oncology team administers systemic and immunotherapy regimens per EASL and AASLD guidelines, and palliative care is integrated from diagnosis for advanced-stage patients. Patients across Chhattisgarh access this full spectrum of care locally, removing the cost and burden of travel to distant metropolitan centres.